New antibody therapy aims to shield kids with rare immune disorder
NCT ID NCT04944979
First seen Nov 18, 2025 · Last updated May 16, 2026 · Updated 28 times
Summary
This study tests a medicine called Kedrion IVIg 10% in 30 children with primary immunodeficiency disease (PID), a condition where the immune system cannot fight infections well. The treatment provides antibodies to help prevent serious bacterial infections. The goal is to see if it is safe and effective for long-term use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY IMMUNODEFICIENCY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Asthma and Allergy Center - Toledo
Toledo, Ohio, 43617, United States
-
Azienda Ospedaliera Universitaria "Federico II"
Naples, Italy
-
Azienda Ospedaliero-Universitaria - Ospedale Pediatrico Meyer
Florence, Italy
-
Benioff Children's Hospital - Mission Bay
San Francisco, California, 94158, United States
-
Centro Hospitalar Lisboa Central - Hospital Dona Estefânia
Lisbon, Portugal
-
Centro Hospitalar Universitário do Porto - Hospital Santo António
Porto, Portugal
-
Children's City Clinical Hospital No. 9 named after G.N. Speransky, Moscow City Health Department
Moscow, Russia
-
Dmitry Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology
Moscow, Russia
-
Duke Children's Hospital & Health Center
Durham, North Carolina, 27706, United States
-
Dél-Pesti Centrumkórház - Országos Hematológiai És Infektológiai Intézet
Budapest, Hungary
-
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinic
Milan, Italy
-
Fondazione Policlinico Tor Vergata
Roma, Italy
-
I.R.C.C.S. Istituto Giannina Gaslini
Genova, Italy
-
IMMUNOe Health and Research Centers
Centennial, Colorado, 80112, United States
-
IRCCS Ospedale Pediatrico Bambino Gesù
Roma, Italy
-
Johns Hopkins All Children's Hospital
St. Petersburg, Florida, 33701, United States
-
Louisiana State University Shreveport
Shreveport, Louisiana, 71103, United States
-
Národný ústav detských chorôb (National Institute of Pediatric Diseases)
Bratislava, Slovakia
-
SST Spedali Civili di Brescia
Brescia, Italy
-
Velocity Clinical Research - MedPharmics - Lafayette
Lafayette, Louisiana, 70508, United States
-
Vital Prospects Clinical Research Institute PC
Tulsa, Oklahoma, 74136, United States
Conditions
Explore the condition pages connected to this study.